Medicines Patent Pool Sublicenses New Antibiotic Candidate To TB Alliance For Development
TB Alliance and the Medicines Patent Pool announced today a licensing agreement for the development of sutezolid, a new antibiotic drug candidate which may be used to treat tuberculosis.









